Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.125
-0.005 (-0.23%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $721.80 million as of April 25, 2025. Its market cap has increased by 2.02% in one year.
Market Cap
721.80M
Enterprise Value
229.72M
1-Year Change
2.02%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $721.80M, an increase of 313.69%. That is a compound annual growth rate of 35.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 723.49M | -19.19% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.41B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |